This study investigates the sex steroid hormone profile in younger men with distal radius fracture (DRF) in order to elucidate if this could explain the low bone density and osteoporosis previously observed. In a case-control study 73 men with DRF (mean age 38±9; range 20-51) was compared to 194 age-matched, population controls. Performed assays: total testosterone (TT), calculated free testosterone (cFT), luteinizing hormone (LH), follicle stimulating hormone (FSH), sex hormone binding globulin (SHBG), and total estradiol (E2). BMD hip and spine were measured. Fracture cases had lower cFT (298 vs 329 pmol/l; p=0.008) but not TT, compared to controls. FSH and SHBG were not statistically different. LH was almost 30% higher (5.7 vs 4.5 IU/l; p<0.001) and a lower E2 was observed (80.0 vs 87.1, p=0.098). Men with DRF had lower E2/SHBG ratio compared to controls (2.3 vs 2.9, p=0.013). A higher proportion of the fracture group had low TT (<10.5 nmol/L) 21% vs 11%, p=0.052, low cFT (<220 pmol/L) 18% vs 8%, p=0.017 and low E2 (<73 pmol/l) 48% vs 35%, p=0.044). Odds ratio for fracture when having low cFT was 2.3 (95% CI 1.02-5.49, p=0.044) and with low E2 1.7 (95% CI 0.96-2.96). In this study in young men with distal radius fracture exploring sex hormone levels, we find that sex hormone profiles may be disturbed with lower E2/SHBG ratio, lower cFT and higher luteinizing hormone. Estrogen is a strong determinant of bone mass also in men; hence, low levels of estradiol may be contributing to the observed lower BMD and these differences may be relevant to fracture risk.